All In Biotech

Free tool

FAERS Monitor: Dovonex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020554 or its brand name (Dovonex, Calcipotriene). Reports on generic versions are filed under their own applications.

Reports

3,398

Serious

1,388

41% of reports

Hospitalization

485

Death reported

69

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective832
  • psoriasis718
  • diarrhoea210
  • arthralgia200
  • rash187
  • nausea186
  • pain182
  • pruritus177
  • off label use173
  • headache169
  • product use in unapproved indication156
  • therapeutic product effect incomplete144
  • fatigue142
  • psoriatic arthropathy137
  • product dose omission issue123

Reports by year received

View as table
YearReports
20046
200510
200612
200716
200831
200921
201024
20116
201224
201349
201452
2015130
2016140
2017164
2018164
2019235
2020216
2021225
2022215
2023942
2024251
2025263
2026202

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,761 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
psoriasisSignal71834.232.123,131
psoriatic arthropathySignal13721.017.82,580
therapeutic product effect incompleteSignal14412.610.71,522
drug ineffectiveSignal8323.93.71,918
product use in unapproved indicationSignal1563.93.3337
arthralgiaSignal2003.02.6266
pruritusSignal1772.92.5215
rashSignal1872.72.3195
product dose omission issueSignal1232.62.2120
diarrhoeaSignal2102.01.8110
pain1821.81.670
headache1691.71.446
nausea1861.51.327
off label use1731.21.17
fatigue1421.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.